Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
27 participants
INTERVENTIONAL
2023-09-07
2023-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
At time T1 (second week) and time T2 (third week) the DASS-21 will initially be administered followed by two weekly treatments with a visor. At the end (T3) the compilation of both tests (Mini-Z survey 2.0-the single item burnout question and the DASS-21) will be repeated following the last two applications of the viewer.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Virtual Reality Relaxation Intervention for Clinical Staff
NCT05601908
VR Embodiment for Stress Evaluation in a Return to Work Simulation
NCT05379764
Virtual Reality Therapy to Improve Physical and Psychological Symptoms and Quality of Life for End-of-life Patients on a Palliative Care Unit
NCT04966260
Virtual Reality Program to Reduce Stress in Neonatal Nurses
NCT06192368
Virtual Reality for Improving Symptoms in Palliative Care
NCT05197894
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Virtual reality
visor
The treatment will have a duration of 4 weeks, with the execution of two sessions per week with the use of a viewer positioned on the head that allows users to navigate and interact in real time with a three-dimensional (3D) environment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
visor
The treatment will have a duration of 4 weeks, with the execution of two sessions per week with the use of a viewer positioned on the head that allows users to navigate and interact in real time with a three-dimensional (3D) environment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Absence of neurological pathologies
* personnel who actively engage in membership/participation during all 4 weeks of the project
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda Ospedaliera di Padova
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anna Marinetto, RN
RN
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zanin
Role: PRINCIPAL_INVESTIGATOR
Azienda Ospedale-Università Padova
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospice Pediatrico- Azienda Ospedale Università Padova
Padua, PD, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ppcVirtualReality
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.